Equity Capital Markets

Inhibikase Therapeutics

05/22
|
$98.0 Million
Inhibikase Therapeutics
Piper Sandler served as placement agent for Inhibikase Therapeutics on an ATM offering
Sub-Type
At the Market Offering
Sub-Sector
Biopharma